Document is current
Any future updates will be listed below
-
Authors
Sng, Xavier Y. X. https://orcid.org/0000-0001-7424-2123
Voigt, Valentina https://orcid.org/0000-0002-2265-7914
Schuster, Iona S. https://orcid.org/0000-0001-6219-9009
Fleming, Peter https://orcid.org/0000-0002-3230-9091
Deuss, Felix A. https://orcid.org/0000-0002-0386-4336
Abuwarwar, Mohammed H. https://orcid.org/0000-0002-0852-8542
van Dommelen, Serani L. H. https://orcid.org/0000-0001-5165-9241
Neate, Georgia E. G. https://orcid.org/0000-0001-5439-9027
Arnold, Riley M. https://orcid.org/0009-0003-2100-1467
Horsnell, Harry L. https://orcid.org/0000-0002-4321-6958
Daly, Sheridan https://orcid.org/0000-0002-9865-2124
Golzarroshan, Bagher
Varelias, Antiopi
Lyman, Stewart D.
Scalzo, Anthony A.
Hill, Geoffrey R.
Mueller, Scott N. https://orcid.org/0000-0002-3838-3989
Wikstrom, Matthew E. https://orcid.org/0009-0005-4545-8319
Berry, Richard
Rossjohn, Jamie https://orcid.org/0000-0002-2020-7522
Fletcher, Anne L.
Andoniou, Christopher E. https://orcid.org/0000-0003-0566-3180
Degli-Esposti, Mariapia A. https://orcid.org/0000-0002-7808-5935
- License Information
-
More Information
Article History
Received: 3 January 2024
Accepted: 2 December 2025
First Online: 21 January 2026
Competing interests
: The Lions Eye Institute have submitted a PCT patent application (WO2025080875) relating to stromal CD44 regulation of T cell responses; the application involves M.A.D.-E., C.E.A., R.B., J.R. and A.A.S. The other authors declare no competing interests.
